Background illustration for clinical trials search

Paid Clinical Trials Berkeley

Discover 2,272 paid clinical trials in Berkeley, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

for
COVID-19, SARS-CoV-2 Infection
Location: San Francisco CA, Los Angeles CA
Sponsor: Kara Chew

Sex: All

Age: 40 - 64

Code: NCT06810934

Phase1, Phase2, Recruiting

Effect of Fetal Aortic Valvuloplasty on Outcomes

for
Congenital Heart Disease, Aortic Valve Stenosis,
Location: San Francisco CA, Columbus OH, Toronto
Sponsor: Queen Silvia Children's Hospital, Gothenburg, Sweden

Sex: All

Age: 0

Code: NCT05386173

Recruiting

Naltrexone for Overdose Prevention

for
Overdose Accidental
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06633900

Phase2, Phase3, Recruiting

Glutide for Ending Methamphetamine

for
Methamphetamine-dependence
Location: San Francisco CA
Sponsor: San Francisco Department of Public Health

Sex: All

Age: 18 - 65

Code: NCT07204249

Phase2, Recruiting

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

for
Amyotrophic Lateral Sclerosis (ALS)
Location: San Francisco CA, La Jolla CA, Seattle WA, Lincoln NE,
Sponsor: Zydus Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07023835

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

for
Sensorineural Hearing Loss, Bilateral
Location: San Francisco CA, Iowa City IA, Nashville TN,
Sponsor: Akouos, Inc.

Sex: All

Age: 0+

Code: NCT05821959

Phase1, Phase2, Recruiting

Autologous Gene Therapy for Artemis-Deficient SCID

for
Severe Combined Immunodeficiency
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 0+

Code: NCT03538899

Phase1, Phase2, Recruiting

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

for
Idiopathic Inflammatory Myopathy, Dermatomyositis,
Location: San Francisco CA, Orange CA, Portland OR,
Sponsor: Cabaletta Bio

Sex: All

Age: 6 - 70+

Code: NCT06154252

Phase2, Phase3, Recruiting

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

for
Crohn Disease
Location: San Francisco CA, Los Angeles CA, Phoenix AZ,
Sponsor: Connecticut Children's Medical Center

Sex: All

Age: 6 - 17

Code: NCT05781152

Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

for
Lupus Nephritis
Location: San Francisco CA, Loma Linda CA, Aurora CO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 5 - 17

Code: NCT05039619

Phase2, Recruiting

A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

for
AADC Deficiency
Location: San Francisco CA, Columbus OH
Sponsor: Krzysztof Bankiewicz

Sex: All

Age: 2+

Code: NCT02852213

Phase1, Recruiting

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

for
Alpha1-Antitrypsin Deficiency
Location: San Francisco CA, Los Angeles CA, La Jolla CA,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06165341

Phase3, Recruiting

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

for
Breast Cancer
Location: San Francisco CA, Houston TX, Chicago IL, Nashville TN,
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18+

Code: NCT03990896

Phase2, Recruiting

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

for
Pulmonary Arterial Hypertension
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 1 - 17

Code: NCT05587712

Phase2, Recruiting

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

for
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Location: San Francisco CA, Palo Alto CA, Denver CO,
Sponsor: SeaStar Medical

Sex: All

Age: 0 - 22

Code: NCT06517810

Recruiting

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

for
Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Neoplasms,
Location: San Francisco CA, Los Angeles CA, Orange CA, Boston MA
Sponsor: Eureka Therapeutics Inc.

Sex: All

Age: 1 - 21

Code: NCT04634357

Phase1, Phase2, Recruiting

Pulmonary Hypertension Association Registry

for
Pulmonary Arterial Hypertension,
Location: San Francisco CA, Stanford CA, Sacramento CA,
Sponsor: Pulmonary Hypertension Association, Inc.

Sex: All

Age: 0+

Code: NCT04071327

Recruiting

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

for
Myasthenia Gravis
Location: San Francisco CA, Palo Alto CA, Phoenix AZ, Aurora CO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 2 - 17

Code: NCT05265273

Phase2, Phase3, Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

for
Dravet Syndrome
Location: San Francisco CA, Portland OR, Aurora CO, Fort Worth TX,
Sponsor: Encoded Therapeutics

Sex: All

Age: 0 - 17

Code: NCT05419492

Phase1, Phase2, Recruiting

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

for
Liver Transplant
Location: San Francisco CA, Chicago IL, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 13

Code: NCT07549503

Phase2, Recruiting